Precision BioSciences Inc
(NAS:DTIL)
$
9.69
-0.03 (-0.31%)
Market Cap: 70.09 Mil
Enterprise Value: -22.67 Mil
PE Ratio: 31.26
PB Ratio: 0.92
GF Score: 59/100 Precision BioSciences Inc (DTIL) Transcripts
- Precision BioSciences Inc Extraordinary Shareholders Meeting TranscriptJan 18, 2024
- Precision BioSciences Inc at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Precision BioSciences Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 04, 2023
- Precision BioSciences Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 03, 2023
- Precision BioSciences Inc at HC Wainwright Cell Therapy Virtual Conference TranscriptFeb 28, 2023
- Precision BioSciences Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Precision BioSciences Inc Announces In Vivo Gene Editing Collaboration with Novatris TranscriptJun 22, 2022
- Precision BioSciences Inc Allogeneic CAR T Update- Conference Call TranscriptJun 08, 2022
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 10, 2022
- Precision BioSciences Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 27, 2021
- Precision BioSciences Inc PBCAR0191 Clinical Data Call TranscriptJun 04, 2021
- Precision BioSciences Inc Annual Shareholders Meeting TranscriptMay 10, 2021
- Precision BioSciences Inc Reacquires Global Rights to its Allogeneic CAR T Programs- Conference Call TranscriptApr 15, 2021
- Precision BioSciences Inc at Truist Securities Life Sciences Summit (April Series) TranscriptApr 13, 2021
- Precision BioSciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Cell Gene Meeting on the Mesa - Precision BioSciences TranscriptJan 08, 2021
- Precision BioSciences Inc Interim Data Results for PBCAR0191- Conference Call TranscriptDec 04, 2020
- Precision BioSciences Inc and Eli Lilly and Co In Vivo Gene Editing Collaboration - Conference Call TranscriptNov 20, 2020
- 1